8 results
How does the 2019 Novel Coronavirus (nCoV2019) compare to Ebola, SARS, MERS? Cases and Deaths
Weighing diseases
Novel Coronavirus ... to tell how far nCoV ... 813 deaths MERS coronavirus ... -nCoV (December ... deaths #cases #COVID19
*Coronavirus Update*: investigational remdesivir for the treatment of COVID-19. Here is a quick highlight of two
*Coronavirus Update ... remdesivir for the treatment ... #Coronavirus #Covid ... -19 #covid19 #2019 ... -nCov #RespiratoryDisease
Criteria for Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) / COVID-19

Fever or signs/symptoms of lower
Novel Coronavirus ... (2019-nCoV) / COVID ... -nCoV patient within ... Investigation #Novel #Coronavirus ... #nCoV2019 #COVID19
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... US and updated treatment ... Disease 2019 a.k.a ... : SARS-CoV-2, 2019 ... Novel Coronavirus
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
activity against SARS-CoV ... virus causing COVID ... ivermectin… #COVID19 ... #Coronavirus #SARS-CoV ... #Pharmacology #Treatment
Convalescent Plasma in COVID-19: Why It Might Work
Convalescent plasma (CP) as a passive antibody therapy has
Convalescent Plasma in COVID ... during the 1918 and 2009 ... Therefore, this treatment ... COVID-19) and thus ... #sarscov2 #coronavirus
Persistence of clinically relevant viruses on dry inanimate surfaces

Most common viruses persist on surfaces for days
The novel coronavirus ... days to 3 months Coronavirus ... 80% similar to 2019 ... -nCoV) Coxsackie ... contagiousness #COVID19
Reported Mechanisms and Toxicity of Investigational Treatments for SARS-COV-2
Chloroquine and Hydroxychloroquine
 • Mechanisms: Interference with ligand
Investigational Treatments ... for SARS-COV-2 ... Medications #SARSCOV2 #COVID19 ... #Coronavirus